These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2373973

  • 1. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA, Fink G, Sheward WJ.
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [Abstract] [Full Text] [Related]

  • 2. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.
    Fink G, Robinson IC, Tannahill LA.
    J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063
    [Abstract] [Full Text] [Related]

  • 3. Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampus.
    Tannahill LA, Sheward WJ, Robinson IC, Fink G.
    J Endocrinol; 1991 Apr; 129(1):99-107. PubMed ID: 2030335
    [Abstract] [Full Text] [Related]

  • 4. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM, Sawchenko PE.
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [Abstract] [Full Text] [Related]

  • 5. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.
    Sheward WJ, Fink G.
    J Endocrinol; 1991 Apr; 129(1):91-8. PubMed ID: 2030334
    [Abstract] [Full Text] [Related]

  • 6. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB, Sutton S, Otto S, Plotsky PM.
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [Abstract] [Full Text] [Related]

  • 7. Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood.
    Tannahill LA, Dow RC, Fairhall KM, Robinson IC, Fink G.
    Neuroendocrinology; 1988 Dec; 48(6):650-7. PubMed ID: 2855106
    [Abstract] [Full Text] [Related]

  • 8. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO, Plotsky PM, Vale WW.
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [Abstract] [Full Text] [Related]

  • 9. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM, Lee S, Rivier C.
    Brain Res; 1997 Jan 02; 744(1):83-95. PubMed ID: 9030416
    [Abstract] [Full Text] [Related]

  • 10. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E, Giacomini M, Jacquier MC, Gaillard RC.
    Neuroendocrinology; 1991 Feb 02; 53(2):160-70. PubMed ID: 1849620
    [Abstract] [Full Text] [Related]

  • 11. Oxytocin and vasopressin in rat hypophysial portal blood: experimental studies in normal and Brattleboro rats.
    Horn AM, Robinson IC, Fink G.
    J Endocrinol; 1985 Feb 02; 104(2):211-24. PubMed ID: 3968510
    [Abstract] [Full Text] [Related]

  • 12. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry.
    Walker CD, Tilders FJ, Burlet A.
    J Neuroendocrinol; 2001 Jan 02; 13(1):74-85. PubMed ID: 11123517
    [Abstract] [Full Text] [Related]

  • 13. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D, Pham T, Fullerton MJ, Ooi G, Funder JW, Clarke IJ.
    Neuroendocrinology; 1989 Apr 02; 49(4):367-81. PubMed ID: 2541360
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of corticotropin release during hypothermia: the role of corticotropin-releasing factor, vasopressin, and oxytocin.
    Gibbs DM.
    Endocrinology; 1985 Feb 02; 116(2):723-7. PubMed ID: 2981677
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical localization of corticotropin-releasing factor, [arginine8]-vasopressin and oxytocin neurons in the goat hypothalamus.
    Kikusui T, Takeuchi Y, Mori Y.
    J Vet Med Sci; 1997 Aug 02; 59(8):621-8. PubMed ID: 9300356
    [Abstract] [Full Text] [Related]

  • 16. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
    Hashimoto K, Yunoki S, Kageyama J, Ohno N, Takahara J, Ofuji T.
    Neuroendocrinology; 1981 Feb 02; 32(2):87-91. PubMed ID: 6259547
    [Abstract] [Full Text] [Related]

  • 17. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by corticotropin-releasing factor.
    Plotsky PM, Bruhn TO, Otto S.
    Endocrinology; 1985 Apr 02; 116(4):1669-71. PubMed ID: 3871693
    [Abstract] [Full Text] [Related]

  • 18. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids.
    Dong W, Seidel B, Marcinkiewicz M, Chrétien M, Seidah NG, Day R.
    J Neurosci; 1997 Jan 15; 17(2):563-75. PubMed ID: 8987779
    [Abstract] [Full Text] [Related]

  • 19. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    Whitnall MH.
    J Comp Neurol; 1988 Sep 01; 275(1):13-28. PubMed ID: 3262632
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy.
    Kovács K, Kiss JZ, Makara GB.
    Neuroendocrinology; 1986 Sep 01; 44(2):229-34. PubMed ID: 3540700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.